Table 2.
Groupsa | NOD2 CADD >15 Variants (training set = 484) | NOD2 CADD >15 Variants (testing set = 161) | ||||
---|---|---|---|---|---|---|
Absolute Cut Off Value of GenePy Scorea | Number of Patients in Group (%) | Number of Stricturing Patients in Group | Absolute Cutoff Values | Number of Patients in Group (%) | Number of Stricturing Patients in Group | |
Group 1 (high risk) | ≥1.078 | 59 (12.2%) | 27 (45.7%) | ≥1.078 | 30 (18.6%) | 17 (56.7%) |
Group 2 (low risk) | <1.078 | 425 (87.8%) | 108 (25.4%) | <1.078 | 131 (81.4%) | 28 (21.4%) |
aGroups determined by Fisher exact test.